AzTrials
AzTrials

Environmental ExposureIEQ-HUMNCT05972187

The Effect of IEQ on Cognition and Health

A study testing Temperature and Humidity in people with Environmental Exposure and Temperature Change, Body, run by Maastricht University Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to learn about the effect of heat and humidity on cognition and health. The main question[s] it aims to answer are: type of study: interventional participant population: 20-40years, both gender, healthy Participants will be exposed for 4 different sessions of 8 hours at a time, to 32˚ C or… Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
What is being tested?
Temperature and Humidity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteNetherlands
Study dates
18 Jun 2023to 7 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • BMI between 18.5-26 kg/m2
  • Age between 20-40 years
  • Proficient with the English language in both verbal and written form
  • Healthy; no illness or disease or prescribed medication within the last 3 months
  • Steady dietary and sleeping habits
  • Regularly physically active (i.e., regularly active but less than 3 times a week for less than 2 hours per session at moderate intensity)
  • Non-smoker or person who quit smoking more than five years ago
  • Reside in the Netherlands (or surrounding countries) for at least 6 months

Who cannot join

  • Subjects with cardiac problems and cardiovascular diseases, such as angina pectoris, cardiac infarction, and arrhythmias
  • Subjects with any medical condition requiring treatment and/or medication (except oral contraceptives) that might interfere with the investigated parameters E.g., Extreme chronotype, colour blindness, epilepsy
  • Subjects with a disorder or disease (Parkinson, Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer, diabetes, cardiovascular disorder, respiratory impairments (for example asthma), hypertension, obesity, or any other condition that can impair the lung function), or Raynaud's phenomenon
  • Subjects with abnormal diet and sleeping patters and/or abnormal body weight (weight gain or loss >3kg in the past month)
  • Subjects who recently participated in other interventional biomedical study within 1 month prior to screening visit
  • Subjects, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician will be informed, cannot participate in this study
Show all 12Show fewer
  • Subjects with previous covid infection in the past 3 months or any subject with persistent long covid symptoms that may have caused ongoing loss of or altered sense of smell
  • Subjects who had severely altered sleep patterns in the past year
  • Subjects employed with night shift work within the past year
  • Subjects who consume more than two standard drinks of alcohol per day
  • Subjects who consume more than two standard drinks of coffee per day
  • Subjects who are pregnant

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Maastricht University

    Maastricht

Other trials in Netherlands

About this study

Official title: The Effect of the Indoor Environmental Quality (IEQ) on Cognition and Health

The goal of this study is to learn about the effect of heat and humidity on cognition and health. The main question[s] it aims to answer are:

type of study: interventional participant population: 20-40years, both gender, healthy Participants will be exposed for 4 different sessions of 8 hours at a time, to 32˚ C or 25˚ C in combination with relative humidity of 30 %RH or 70 %RH.

Read the detailed description

Overall, the project aims to evaluate the effects of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on cognition, for longer exposure duration (8 hours). Deviations from the personal comfort zones are expected to affect both subjective feelings and physiological parameters. Therefore, the following parameters will be included: cognition, environmental perception, energy expenditure, body temperatures.

Main research question and primary objective:

What is the impact of being exposed for 8 hours to a high humidity (RH 70%) versus low humidity (RH 30%) on cognitive performance of individuals if the room temperature is 25ºC or 32ºC?

This leads to the following hypotheses:

  • Exposure to an indoor high relative humidity (RH 70%) at a warm temperature (32ºC) of a long duration (8 hours) reduces the composite score, speed and accuracy of cognitive performance compared to an exposure to a low RH (30%) at the same temperature (32ºC) due to the humidity.
  • An exposure to an indoor high relative humidity (RH 70%) at a neutral temperature (25ºC) of a long duration (8 hours) would reduce the composite score, speed and accuracy of cognitive performance compared to an exposure to a low RH (30%) at a neutral temperature (25 ºC) due to previous literature for humidity influences at neutral temperatures.

Secondary research question and secondary objective:

What is the effect of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on physiological responses, environmental perception, decision making, and bias behaviour?

This leads to the following hypotheses:

  1. Does an 8 hour exposure to an elevated concentration of indoor humidity lead to an increase in energy expenditure and/or a greater difference in proximal and distal blood flow and skin temperature gradients compared to a lower indoor humidity for each of the temperature settings?
  2. What are the effects of high humidity on substrate oxidation, blood pressure, heart rate variability, proximal and distal skin temperature, risk behavior and decision-making responses of individuals?
  3. What are the effects of higher humidity on environmental perception (thermal, air quality, moisture/wetness) comfort, perception, and sensation?
  • An exposure to an indoor high relative humidity (RH 70%) at a warm temperature (32ºC) of a long duration (8 hours) reduces the composite score, speed and accuracy of cognitive performance compared to an exposure to a high RH (70%) at a neutral temperature (25 ºC) due to the humidity and temperature.
  • An exposure to an indoor low relative humidity (RH 30%) at a warm temperature (32ºC) of a long duration (8 hours) would reduce the composite score, speed and accuracy of cognitive performance compared to an exposure to the same low RH (30%) at a neutral temperature (25 ºC) due to the temperature.

Exploratory research question and objective:

What is the interaction effect of high vs. neutral temperature (32˚ C vs. 25˚ C) in combination with high vs. low humidity (30 %RH vs. 70 %RH) on cognitive performance, physiological responses, environmental perception, decision making, and bias behaviour?

Being tested
Temperature and Humidity
Keywords
Temperature, Humidity, Thermoregulation, Cognition, Health
Medical subject headings
Body Temperature Changes, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Temperature and HumidityOther

    Temperature and Humidity of room changed

Study groups in NCT05972187
Study groupRoleWhat they receive
Temperature and HumidityExperimental32C or 25C and 30%RH or 70%RH
Receives: Other: Temperature and Humidity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognition

    Using a tablet based cognitive test battery

    Measured: 1 month

Secondary outcomes (5)
  1. Heart Rate (bpm)

    Heart Rate measured using Polar heart rate belt in (bpm) with RR and ECG data extracted

    Measured: 1 month

  2. Blood pressure (mmHg)

    Blood pressure - both systolic and diastolic pressures measured hourly using an automated blood pressure monitor and cuff

    Measured: 1 month

  3. Metabolic Rate (ml O2//min/kg)

    Metabolic rates measured through whole room calorimetry

    Measured: 1 month

  4. Skin Temperature (C)

    Skin temperature measured using thermochron (ibuttons) at multiple sites

    Measured: 1 month

  5. Body Core Temperature (C)

    Core Temperature measured via telemetric pill ingested in the morning

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2023
  2. Study start18 Jun 2023
  3. Primary completion7 May 2024
  4. Study completion7 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05972187
Sponsor's protocol ID
NL81104.068.22
Acronym
IEQ-HUM
Status last verified
Sep 2023
First submitted
24 Mar 2023
Last updated
24 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: If requested raw data will be provided.

Questions about this trial

What is this clinical trial studying?

A study testing Temperature and Humidity in people with Environmental Exposure and Temperature Change, Body, run by Maastricht University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognition (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in